1. Immunomics Datasets and Tools: To Identify Potential Epitope Segments for Designing Chimeric Vaccine Candidate to Cervix Papilloma
    Satyavani Kaliamurthi et al, 2019, Data CrossRef
  2. Classification and identification of human papillomavirus based on its prevalence and development of cervical lesion among Iranian women
    Mitra Moeinzadeh et al, 2020, BioImpacts CrossRef
  3. Prevalence of cervical high-risk human papillomavirus and cytological abnormalities in elderly Turkish women
    Cem YALCINKAYA, 2022, Marmara Medical Journal CrossRef
  4. Distribution of HPV types among women with HPV-related diseases and exploration of lineages and variants of HPV 52 and 58 among HPV-infected patients in China: A systematic literature review
    Meng Wang et al, 2024, Human Vaccines & Immunotherapeutics CrossRef
  5. Genotype distribution and prevalence of human papillomavirus among women with cervical cytological abnormalities in Xinjiang, China
    Jing Wang et al, 2019, Human Vaccines & Immunotherapeutics CrossRef
  6. Exploring the Papillomaviral Proteome to Identify Potential Candidates for a Chimeric Vaccine against Cervix Papilloma Using Immunomics and Computational Structural Vaccinology
    Satyavani Kaliamurthi et al, 2019, Viruses CrossRef
  7. LINC00511 promotes cervical cancer progression by regulating the miR-497-5p/MAPK1 axis
    Mingming Lu et al, 2022, Apoptosis CrossRef